Khuloud T. Al-Jamal, PhD
Affiliations: | 2011-2024 | Institute of Pharmaceutical Science, Faculty of Life Science & Medicine | King's College London, London, UK |
| 2024- | Pharmacology and Pharmacy, LKS Faculty of Medicine | Hong Kong University, Hong Kong, Hong Kong |
Area:
Nanomedicine, Drug DeliveryWebsite:
https://kclpure.kcl.ac.uk/portal/khuloud.al-jamal.htmlGoogle:
"Khuloud Al-Jamal"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Alexander T. Florence | grad student | 2005 | University of London |
| Kostas Kostarelos | post-doc | 2005-2011 | University of London |
Children
Sign in to add traineeCollaborators
Sign in to add collaborator| N Joan Abbott | collaborator | (Physiology Academic Tree) | |
| Robert Charles Hider | collaborator | ||
| Jane Sosabowski | collaborator |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Rouatbi N, Walters AA, Zam A, et al. (2025) CD47 Knock-Out Using CRISPR-Cas9 RNA Lipid Nanocarriers Results in Reduced Mesenchymal Glioblastoma Growth In Vivo. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). e2407262 |
| Baker RS, Wang JT, Rouatbi N, et al. (2025) Brain distribution study of [C]-Riluzole following intranasal administration in mice. International Journal of Pharmaceutics. 670: 125195 |
| Brüßeler MMT, Zam A, Moreno-Zafra VM, et al. (2024) Polyinosinic/Polycytidylic Lipid Nanoparticles Enhance Immune Cell Infiltration and Improve Survival in the Glioblastoma Mouse Model. Molecular Pharmaceutics. 21: 6339-6352 |
| Rouatbi N, Walters AA, Costa PM, et al. (2024) RNA lipid nanoparticles as efficient in vivo CRISPR-Cas9 gene editing tool for therapeutic target validation in glioblastoma cancer stem cells. Journal of Controlled Release : Official Journal of the Controlled Release Society |
| Li YT, Mei KC, Liam-Or R, et al. (2024) Graphene Oxide Nanosheets Toxicity in Mice Is Dependent on Protein Corona Composition and Host Immunity. Acs Nano |
| Qin Y, Rouatbi N, Wang JT, et al. (2024) Plasmid DNA Ionisable lipid nanoparticles as non-inert carriers and potent immune activators for cancer immunotherapy. Journal of Controlled Release : Official Journal of the Controlled Release Society |
| Liam-Or R, Faruqu FN, Walters A, et al. (2024) Cellular uptake and in vivo distribution of mesenchymal-stem-cell-derived extracellular vesicles are protein corona dependent. Nature Nanotechnology |
| Han S, Al-Jamal KT. (2023) Combined Facile Synthesis, Purification, and Surface Functionalization Approach Yields Monodispersed Gold Nanorods for Drug Delivery Applications. Particle & Particle Systems Characterization : Measurement and Description of Particle Properties and Behavior in Powders and Other Disperse Systems. 40: 2300043 |
| Graham R, Gazinska P, Zhang B, et al. (2023) Serum-derived extracellular vesicles from breast cancer patients contribute to differential regulation of T-cell-mediated immune-escape mechanisms in breast cancer subtypes. Frontiers in Immunology. 14: 1204224 |
| Lu Y, Wang JT, Li N, et al. (2023) Intranasal administration of edaravone nanoparticles improves its stability and brain bioavailability. Journal of Controlled Release : Official Journal of the Controlled Release Society |